These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27146052)

  • 1. Surviving Sepsis in the Intensive Care Unit: The Challenge of Antimicrobial Resistance and the Trauma Patient.
    Ramsamy Y; Hardcastle TC; Muckart DJJ
    World J Surg; 2017 May; 41(5):1165-1169. PubMed ID: 27146052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
    Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
    BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
    Vincent JL; Bihari DJ; Suter PM; Bruining HA; White J; Nicolas-Chanoin MH; Wolff M; Spencer RC; Hemmer M
    JAMA; 1995 Aug 23-30; 274(8):639-44. PubMed ID: 7637145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive care unit-acquired urinary tract infections in patients admitted with sepsis: etiology, risk factors, and patterns of antimicrobial resistance.
    Mojtahedzadeh M; Panahi Y; Fazeli MR; Najafi A; Pazouki M; Navehsi BM; Bazzaz A; Naghizadeh MM; Beiraghdar F
    Int J Infect Dis; 2008 May; 12(3):312-8. PubMed ID: 18032082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study.
    Saravu K; Prasad M; Eshwara VK; Mukhopadhyay C
    Pathog Glob Health; 2015 Jul; 109(5):228-35. PubMed ID: 26184918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of bloodstream infections in ICUs.
    Timsit JF; Soubirou JF; Voiriot G; Chemam S; Neuville M; Mourvillier B; Sonneville R; Mariotte E; Bouadma L; Wolff M
    BMC Infect Dis; 2014 Nov; 14():489. PubMed ID: 25431091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intensive care unit in antimicrobial resistance.
    Koleff MH
    Postgrad Med; 2001 Feb; 109(2 Suppl):60-9. PubMed ID: 19667559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality.
    Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Fernández-Delgado E; López-Sánchez JM
    Crit Care; 2015 Aug; 19(1):302. PubMed ID: 26307060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.
    Garnacho-Montero J; Ortiz-Leyba C; Herrera-Melero I; Aldabó-Pallás T; Cayuela-Dominguez A; Marquez-Vacaro JA; Carbajal-Guerrero J; Garcia-Garmendia JL
    J Antimicrob Chemother; 2008 Feb; 61(2):436-41. PubMed ID: 18056733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.
    De Waele JJ; Akova M; Antonelli M; Canton R; Carlet J; De Backer D; Dimopoulos G; Garnacho-Montero J; Kesecioglu J; Lipman J; Mer M; Paiva JA; Poljak M; Roberts JA; Rodriguez Bano J; Timsit JF; Zahar JR; Bassetti M
    Intensive Care Med; 2018 Feb; 44(2):189-196. PubMed ID: 29288367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Practical Approach to Clinical Antibiotic Stewardship in the ICU Patient with Severe Infection.
    Fierens J; Depuydt PO; De Waele JJ
    Semin Respir Crit Care Med; 2019 Aug; 40(4):435-446. PubMed ID: 31585470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-negative sepsis in the intensive care unit: avoiding therapeutic failure.
    Chapman S; Iredell JR
    Curr Opin Infect Dis; 2008 Dec; 21(6):604-9. PubMed ID: 18978528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
    Adrie C; Garrouste-Orgeas M; Ibn Essaied W; Schwebel C; Darmon M; Mourvillier B; Ruckly S; Dumenil AS; Kallel H; Argaud L; Marcotte G; Barbier F; Laurent V; Goldgran-Toledano D; Clec'h C; Azoulay E; Souweine B; Timsit JF;
    J Infect; 2017 Feb; 74(2):131-141. PubMed ID: 27838521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study.
    Agaba P; Tumukunde J; Tindimwebwa JVB; Kwizera A
    BMC Res Notes; 2017 Jul; 10(1):349. PubMed ID: 28754148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in intensive care units.
    Fridkin SK; Gaynes RP
    Clin Chest Med; 1999 Jun; 20(2):303-16, viii. PubMed ID: 10386258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
    Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
    J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?
    Heenen S; Jacobs F; Vincent JL
    Crit Care Med; 2012 May; 40(5):1404-9. PubMed ID: 22430235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.